ENDO 2023
What's new and known about HPP
www.high5endocrinology.tv | Meeting coverage | ENDO 2023
ENDO 2023
What's new and known about HPP
ENDO 2023
Assessment of hypophosphatemic rickets
ENDO 2023
Hypercalcemia of malignancies
ENDO 2023
Androgen deprivation for prostate cancer:…
ENDO 2023
Why do hormone-dependent cancers love bone?
ENDO 2023
Genetic influence on the absorption of bisphosphonates
ACcomplisH
ENDO 2023
Achondroplasia - the more the better
ENDO 2023
Current concepts and challenges in the medical care of…
ENDO 2023
FOP - PET or not PET?
ENDO 2023
No DEXA scan for neurofibromatosis type 1
ENDO 2023
TRAVERSE study
ENDO 2023
Update on rare bone diseases - FOP
ENDO 2023
Phase III PaTHway study
ENDO 2023
Parathyroid hormone - assembly and disassembly
ENDO 2023
The epic debate on vitamin D supplementation in…
OR07-01
ENDO 2023
New human monogenic obesity form by ectopic ASIP…
ENDO 2023
MAFLD: underestimated
ENDO 2023
MC3R are a new link between puberty and nutrital stage
ENDO 2023
Reduction of liver fat by growth hormone - a new…
ENDO 2023
Pharmacological guidelines of obesity in children
ENDO 2023
Should we rethink diagnostics of insulin insufficiency?
ENDO 2023
MAFLD: Guidelines
ENDO 2023
Game changers for obesity treatment!
ENDO 2023
Diabetes and sleep?
ENDO 2023
Setmelanotide as a new therapy for monogenic obesity
ENDO 2023
Effects of hormonal treatment on bone mineralization
ENDO 2023
Effects of gender-affirming hormons in adolescence
ENDO 2023
Cardiovascular risk factors of trangender people
ENDO 2023
Cancer risk in transpeople
ENDO 2023
Management of a baby with 5α-reductase deficiency
ENDO 2023
DSD surgery
ACcomplisH
ENDO 2023
Long-acting CNP
ENDO 2023
Relationship between endocrine and olfactory systems
ENDO 2023
KNDy cells and PCOS?
ENDO 2023
How comlicated is the cycle?
ENDO 2023
The endocrinology of of stress and burnout
ENDO 2023
Genes of pituitary hormone deficiencies
ENDO 2023
Impulse control disorders in dopamine agonist treated…
ENDO 2023
KNDy cells
ENDO 2023
Oxytocin deficiency in patients with diabetes…
ENDO 2023
The growth hormone receptor in the nucleus - what does…
ENDO 2023
Neuroendocrine dysfunction and after brain injury
ENDO 2023
New aspects in the PCOS guideline
ENDO 2023
Why is central DI so difficult?
ENDO 2023
Hypogonadism in man with CAH
ENDO 2023
Primary hypoaldosteronism
ENDO 2023
Diagnosis of cushing's syndrome
ENDO 2023
The relevance of 11-oxygenated androgens
ENDO 2023
Biomarker in non-classic CAH
ENDO 2023
Breastfeeding is not only good for the child - also for…
ENDO 2023
Hidden dangers in dietary-supplements, natural products…
ENDO 2023
Climate and health - health and climate
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend.
Jetzt gleich den Fragebogen ausfüllen!